Skip to main content
SpringerLink
Log in

Central Aortic Pressure, Arterial Compliance: Emerging Tools to Identify and Guide Therapy for High-Risk African American Patients

  • Chapter
  • First Online:
Hypertension in High Risk African Americans

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

  • 667 Accesses

Abstract

African Americans have significantly higher burden of hypertension and related cardiovascular morbidity and mortality. However, the greater cardiovascular risk in African Americans cannot entirely be accounted for by the difference in the traditional peripheral brachial blood pressure (BP). Central aortic pressure and arterial compliance can be fairly easily and accurately measured clinically using applanation tonometry and are emerging as better predictors of blood pressure-related cardiovascular risk. Measuring central aortic pressure and arterial compliance is poised to become an increasingly important part of the routine assessment of hypertension and associated cardiovascular risks and will aide in assessing the effects of related therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233–41.

    Article  PubMed  Google Scholar 

  2. Flack JM, Ferdinand KC, Nasser SA. Epidemiology of hypertension and cardiovascular disease in African Americans. J Clin Hypertens (Greenwich). 2003;5:5–11.

    Article  Google Scholar 

  3. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275:1571–6.

    Article  CAS  PubMed  Google Scholar 

  4. O’Rourke MF, Adji A. Basis for use of central blood pressure measurement in office clinical practice. J Am Soc Hypertens. 2008;2:28–38.

    Article  PubMed  Google Scholar 

  5. DeLoach SS, Townsend RR. Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol. 2008;3:184–92.

    Article  PubMed  Google Scholar 

  6. Williams B, Lacy PS. Central aortic pressure and clinical outcomes. J Hypertens. 2009;27:1123–5.

    Article  CAS  PubMed  Google Scholar 

  7. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.

    Article  PubMed  Google Scholar 

  8. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165:2098–104.

    Article  PubMed  Google Scholar 

  9. Collins R, Winkleby MA. African American women and men at high and low risk for hypertension: a signal detection analysis of NHANES III, 1988-1994. Prev Med. 2002;35:303–12.

    Article  PubMed  Google Scholar 

  10. Howard G, Prineas R, Moy C, et al. Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study. Stroke. 2006;37:1171–8.

    Article  PubMed  Google Scholar 

  11. Gillum RF. The epidemiology of cardiovascular disease in black Americans. N Engl J Med. 1996;335:1597–9.

    Article  CAS  PubMed  Google Scholar 

  12. Clark LT, Emerole O. Coronary heart disease in African Americans: primary and secondary prevention. Cleve Clin J Med. 1995;62:285–92.

    Article  CAS  PubMed  Google Scholar 

  13. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation. 2000;102:3137–47.

    Article  CAS  PubMed  Google Scholar 

  14. Lackland DT, Egan BM, Jones PJ. Impact of nativity and race on “Stroke Belt” mortality. Hypertension. 1999;34:57–62.

    Article  CAS  PubMed  Google Scholar 

  15. Thomas J, Thomas DJ, Pearson T, Klag M, Mead L. Cardiovascular disease in African American and white physicians: the Meharry Cohort and Meharry-Hopkins Cohort Studies. J Health Care Poor Underserved. 1997;8:270–83; discussion 84.

    Article  CAS  PubMed  Google Scholar 

  16. Clark LT, Ferdinand KC, Flack JM, et al. Coronary heart disease in African Americans. Heart Dis. 2001;3:97–108.

    Article  CAS  PubMed  Google Scholar 

  17. Steinberger J, Daniels SR; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young); American Heart Association Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation. 2003;107:1448–53.

    Google Scholar 

  18. Saunders E. Hypertension in blacks. Med Clin North Am. 1987;71:1013–29.

    CAS  PubMed  Google Scholar 

  19. Frohlich ED, Messerli FH, Dunn FG, Oigman W, Ventura HO, Sundgaard-Riise K. Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab. 1984;10:173–7.

    CAS  PubMed  Google Scholar 

  20. Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J. 1991;121:664–9.

    Article  CAS  PubMed  Google Scholar 

  21. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997;277:1293–8.

    Article  CAS  PubMed  Google Scholar 

  22. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14:2902–7.

    Article  PubMed  Google Scholar 

  23. Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP. Renal insufficiency in treated essential hypertension. N Engl J Med. 1989;320:684–8.

    Article  CAS  PubMed  Google Scholar 

  24. Appel LJ, Wright Jr JT, Greene T, et al. Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med. 2008;168:832–9.

    Article  CAS  PubMed  Google Scholar 

  25. Pogue V, Rahman M, Lipkowitz M, et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension. 2009;53:20–7.

    Article  CAS  PubMed  Google Scholar 

  26. Jafar TH, Stark PC, Schmid CH, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003;139:244–52.

    Article  CAS  PubMed  Google Scholar 

  27. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2006 annual data report. Am J Kidney Dis. 2007;49(A6–7):S1–296.

    Google Scholar 

  28. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA. 1992;268:3079–84.

    Article  CAS  PubMed  Google Scholar 

  29. McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis. 1988;12:285–90.

    Article  CAS  PubMed  Google Scholar 

  30. Kao WH, Klag MJ, Meoni LA, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 2008;40:1185–92.

    Article  CAS  PubMed  Google Scholar 

  31. Genovese G, Friedman DJ, Pollak MR. APOL1 variants and kidney disease in people of recent African ancestry. Nat Rev Nephrol. 2013;9:240–4.

    Article  CAS  PubMed  Google Scholar 

  32. Friedman DJ, Kozlitina J, Genovese G, Jog P, Pollak MR. Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol. 2011;22:2098–105.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Lipkowitz MS, Freedman BI, Langefeld CD, et al. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int. 2013;83:114–20.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Tarver-Carr ME, Powe NR, Eberhardt MS, et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol. 2002;13:2363–70.

    Article  PubMed  Google Scholar 

  35. Perneger TV, Whelton PK, Klag MJ. Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med. 1995;155:1201–8.

    Article  CAS  PubMed  Google Scholar 

  36. Freedman BI, Spray BJ, Tuttle AB, Buckalew Jr VM. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis. 1993;21:387–93.

    Article  CAS  PubMed  Google Scholar 

  37. Lei HH, Perneger TV, Klag MJ, Whelton PK, Coresh J. Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol. 1998;9:1270–6.

    CAS  PubMed  Google Scholar 

  38. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753–60.

    Article  PubMed  Google Scholar 

  39. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–605.

    Article  PubMed  Google Scholar 

  40. Franklin SS, Wt G, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308–15.

    Article  CAS  PubMed  Google Scholar 

  41. London G, Guerin A, Pannier B, Marchais S, Benetos A, Safar M. Increased systolic pressure in chronic uremia. Role of arterial wave reflections. Hypertension. 1992;20:10–9.

    Article  CAS  PubMed  Google Scholar 

  42. Izzo Jr JL. Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol. 2004;19:341–52.

    Article  PubMed  Google Scholar 

  43. Mitchell GF, Parise H, Benjamin EJ, et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension. 2004;43:1239–45.

    Article  CAS  PubMed  Google Scholar 

  44. O’Rourke MF, Seward JB. Central arterial pressure and arterial pressure pulse: new views entering the second century after Korotkov. Mayo Clin Proc. 2006;81:1057–68.

    Article  PubMed  Google Scholar 

  45. Alvarez JA, Gower BA, Calhoun DA, et al. Serum 25-hydroxyvitamin D and ethnic differences in arterial stiffness and endothelial function. J Clin Med Res. 2012;4:197–205.

    CAS  PubMed Central  PubMed  Google Scholar 

  46. DeLoach SS, Daskalakis C, Gidding S, Falkner B. Central blood pressures are associated with left ventricular mass index among African-American adolescents. Am J Hypertens. 2012;25:41–5.

    Article  PubMed  Google Scholar 

  47. Redelinghuys M, Norton GR, Scott L, et al. Relationship between urinary salt excretion and pulse pressure and central aortic hemodynamics independent of steady state pressure in the general population. Hypertension. 2010;56:584–90.

    Article  CAS  PubMed  Google Scholar 

  48. Ferdinand KC, Pool J, Weitzman R, Purkayastha D, Townsend R. Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial. J Clin Hypertens (Greenwich). 2011;13:366–75.

    Article  CAS  Google Scholar 

  49. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213–25.

    Article  CAS  PubMed  Google Scholar 

  50. Kamran H, Salciccioli L, Bastien C, Castro P, Sharma A, Lazar JM. Effect of beta blockers on central aortic pressure in African-Americans. J Am Soc Hypertens. 2011;5:94–101.

    Article  PubMed  Google Scholar 

  51. Chirinos JA, Kips JG, Roman MJ, et al. Ethnic differences in arterial wave reflections and normative equations for augmentation index. Hypertension. 2011;57:1108–16.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  52. Townsend RR, Wimmer NJ, Chirinos JA, et al. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens. 2010;23:282–9.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Birru MS, Matthews KA, Thurston RC, et al. African-American ethnicity and cardiovascular risk factors are related to aortic pulse-wave velocity progression. Am J Hypertens. 2011;24:809–15.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. McEniery CM, Spratt M, Munnery M, et al. An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension. 2010;56:36–43.

    Article  CAS  PubMed  Google Scholar 

  55. Din-Dzietham R, Couper D, Evans G, Arnett DK, Jones DW. Arterial stiffness is greater in African Americans than in whites: evidence from the Forsyth County, North Carolina, ARIC cohort. Am J Hypertens. 2004;17:304–13.

    Article  PubMed  Google Scholar 

  56. Pierce GL, Zhu H, Darracott K, et al. Arterial stiffness and pulse-pressure amplification in overweight/obese African-American adolescents: relation with higher systolic and pulse pressure. Am J Hypertens. 2013;26:20–6.

    Article  PubMed Central  PubMed  Google Scholar 

  57. Hall JL, Duprez DA, Barac A, Rich SS. A review of genetics, arterial stiffness, and blood pressure in African Americans. J Cardiovasc Transl Res. 2012;5:302–8.

    Article  PubMed Central  PubMed  Google Scholar 

  58. Lemogoum D, Van Bortel L, Van den Abeele W, et al. Effect of beta-adrenergic stimulation on pulse wave velocity in black and white subjects. J Hypertens. 2004;22:2349–53.

    Article  CAS  PubMed  Google Scholar 

  59. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106:2085–90.

    Article  PubMed  Google Scholar 

  60. Shah AS, Dolan LM, Gao Z, Kimball TR, Urbina EM. Racial differences in arterial stiffness among adolescents and young adults with type 2 diabetes. Pediatr Diabetes. 2012;13:170–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Arena R, Fei DY, Arrowood JA, Kraft KA. Influence on aerobic fitness on aortic stiffness in apparently healthy Caucasian and African-American subjects. Int J Cardiol. 2007;122:202–6.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Renal, Electrolyte and Hypertension Division, University of Pennsylvania, 1 Founder Pavilion, 3400 Spruce Street, Philadelphia, PA, 19104, USA

    Yonghong Huan M.D., Debbie L. Cohen M.D. & Raymond R. Townsend M.D.

Authors
  1. Yonghong Huan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Debbie L. Cohen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raymond R. Townsend M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raymond R. Townsend M.D. .

Editor information

Editors and Affiliations

  1. Cardiology, Tulane University School of Medicine, New Orleans, Louisiana, USA

    Keith C. Ferdinand

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Huan, Y., Cohen, D.L., Townsend, R.R. (2015). Central Aortic Pressure, Arterial Compliance: Emerging Tools to Identify and Guide Therapy for High-Risk African American Patients. In: Ferdinand, K. (eds) Hypertension in High Risk African Americans. Clinical Hypertension and Vascular Diseases. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2010-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2010-5_10

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2009-9

  • Online ISBN: 978-1-4939-2010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation